Literature DB >> 9127314

Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.

J Piffkò1, A Bànkfalvi, D Ofner, D Rasch, U Joos, K W Schmid.   

Abstract

Standardized silver staining and quantitation of nucleolar organizer regions-associated proteins (AgNORs) on routinely formalin-fixed and paraffin-embedded tissues has been recently established. The present study was designed to assess its applicability and reproducibility on archival oral squamous cell carcinoma specimens, with special emphasis on the invasive tumor front. Standardized image cytometric AgNOR analysis was performed at the invasive zone and central parts of the tumors as well as in adjacent dysplastic and normal oral mucosa by applying a modified silver staining on routinely processed archival tissues after wet autoclave pretreatment for protein retrieval. A statistically highly significant and reproducible difference of all of the four standardized AgNOR parameters evaluated (mean AgNOR number, mean AgNOR area, coefficient of variation (CV) of AgNOR number, and CV of AgNOR area per nucleus) was observed between the different areas assessed; there was a statistically significant gradual decrease in the CV of the AgNOR number from the invasive tumor front to central parts of the carcinomas, from dysplastic mucosa to normal epithelium. The observed increase of AgNORs at the invasive front of oral squamous cell carcinomas seems to indicate a subgroup of tumor cells with increased biosynthetic activity and malignant potential. Wet autoclave pretreatment before silver staining of AgNORs is necessary for a reliable visualization of single AgNOR dots. Second-order statistics of AgNOR features, e.g., CV values, offer a potent and highly reproducible parameter for AgNOR quantitation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9127314

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  Significance of Wet Autoclave Pretreatment in Immunohistochemistry.

Authors:  József Piffkó; Dietmar Öfner; Rita Dreier; Werner Böcker; Kurt Werner
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma.

Authors:  Cheng Wang; Hongzhang Huang; Zhiquan Huang; Anxun Wang; Xiaohua Chen; Lei Huang; Xiaofeng Zhou; Xiqiang Liu
Journal:  J Oral Pathol Med       Date:  2011-04-12       Impact factor: 4.253

3.  Association of PD-L1 and ZEB-1 expression patterns with clinicopathological characteristics and prognosis in oral squamous cell carcinoma.

Authors:  Natsumi Takamaru; Naoyuki Fukuda; Kazuya Akita; Keiko Kudoh; Youji Miyamoto
Journal:  Oncol Lett       Date:  2022-01-10       Impact factor: 2.967

4.  Early detection of oral cancer: PAP and AgNOR staining in brush biopsies.

Authors:  Dinesh V Rajput; Jagdish V Tupkari
Journal:  J Oral Maxillofac Pathol       Date:  2010-07

Review 5.  Molecular changes in invasive front of oral cancer.

Authors:  Mohit Sharma; Parul Sah; Sonal Soi Sharma; Raghu Radhakrishnan
Journal:  J Oral Maxillofac Pathol       Date:  2013-05

6.  Are podoplanin and ezrin involved in the invasion process of the ameloblastomas?

Authors:  Y F Costa; K C Tjioe; S Nonogaki; F A Soares; J R Pereira Lauris; D Tostes Oliveira
Journal:  Eur J Histochem       Date:  2015-02-24       Impact factor: 3.188

7.  Analysis of the invasive edge in primary and secondary oral squamous cell carcinoma: An independent prognostic marker: A retrospective study.

Authors:  Afreen Nadaf; Radhika M Bavle; M Soumya; Sarah D'mello; Moni Abraham Kuriakose; Sindhu Govindan
Journal:  J Oral Maxillofac Pathol       Date:  2016 May-Aug

8.  MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway.

Authors:  Jianya He; Wen Ye; Ni Kou; Kang Chen; Bai Cui; Xiaohong Zhang; Shuhai Hu; Tingjiao Liu; Lan Kang; Xiaojie Li
Journal:  J Cell Mol Med       Date:  2019-11-03       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.